"We will be responding to the two observations within the stipulated time period," Granules Pharmaceuticals Executive Director Priyanka Chigurupati said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jkSTlX
via IFTTT
USFDA issues two observations after inspection of Granules India's Chantilly facility in US
"We will be responding to the two observations within the stipulated time period," Granules Pharmaceuticals Executive Director Priyanka Chigurupati said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jkSTlX
via IFTTT
0 comments:
Post a Comment